Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript
Organon & Co. misses on earnings expectations. Reported EPS is $0.88 EPS, expectations were $0.97. Organon & Co.
Organon & Co. (OGN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 211,453 | $3,975,307 | +215% | 0.77% |
| 2. | Sciencast Management Qing Li | 13,619 | $256,037 | 0.15% | |
| 3. | Beddow Capital Management Ed Beddow And William Tichy | 214,700 | $4,036,000 | +23% | 1.76% |
| 4. | Te Ahumairangi Investment Management Nicholas Bagnall | 129,739 | $2,439 | -10% | 0.42% |
| 5. | Levin Easterly Partners John Murphy | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.36 | 2,720 | Officer | 15,181 | 2024-02-22 | Filing | |
| $33.79 | 3,000 | Director | 3,000 | 2021-08-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 33,523,293 | $483,405,887 | 0.01% | |
| 2. | 30,597,237 | $441,212,158 | 0% | |
| 3. | 10,211,008 | $147,242,735 | 0.04% | |
| 4. | 9,442,763 | $136,164,642 | 0% | |
| 5. | 5,859,028 | $84,487,222 | 0% |
News See All
12 Under-the-Radar Stocks With Massive Upside for 2024
In this piece, we will take a look at the 12 under the radar stocks with massive upside for 2024.
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in.
15 Best Affordable Dividend Stocks To Invest In Right Now
In this article, we will take a detailed look at the 15 Best Affordable Dividend Stocks To Invest In Right Now. For a quick overview of such stocks, read our article 5 Best Affordable Dividend Stocks...
13 Best Pharma Dividend Stocks To Buy in 2024
In this article, we discuss 13 best pharma dividend stocks to buy in 2024.
Organon & Co. (NYSE:OGN) Q4 2023 Earnings Call Transcript
Organon & Co. beats earnings expectations. Reported EPS is $0.88, expectations were $0.8. Organon & Co.
Do You Believe That Organon & Co. (OGN) is a Compelling Prospect for Long-Term, Patient Investors?
Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2023. A copy of the same can be downloaded here.
Organon & Co (OGN) Fell on Missed Consensus
Miller Value Partners, an investment management company, released its “Income Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
13 Best Low-Priced Dividend Stocks To Invest In
In this article, we will take a detailed look at the 13 Best Low-Priced Dividend Stocks To Invest In. For a quick overview of such stocks, read our article 5 Best Low-Priced Dividend Stocks To Invest...
5 Low PE High Dividend Stocks to Buy Now
In this article, we discuss 5 low PE high-dividend stocks to buy now.
Billionaire Hedge Funds
